Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks

NCT ID: NCT00876551

Last Updated: 2010-05-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the short and long term outcome of endoscopic vacuum assisted closure of intrathoracic postsurgical leaks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intrathoracic leakage is a serious complication after esophageal surgery. The reported incidence of esophageal anastomotic leaks after gastrectomy and esophagectomy ranges from 5% to almost 30%. Within the last 10 years endoscopic treatment has changed the approach to intrathoracic anastomotic leakages. Application of metal clips, injection of fibrin glue and placement of self expanding metal or plastic stents (SEMS/SEPS) have been reported to successfully achieve closure of postoperative anastomotic leaks in approximately 66-100%. Alternative endoscopically treatment modalities are welcome especially in cases of failure of the above mentioned endoscopic treatment modalities to prevent the necessity of surgical reintervention which is associated with high mortality or mutilating surgical outcome such as proximal diversion with cervical esophagostomy.

Vacuum-assisted closure (V.A.C.) is an established treatment modality for extensive cutaneous infected wounds. The V.A.C. system device is based on a negative pressure applied to the wound via a vacuum sealed sponge tissue. The sponge results in formation of granulation tissue, while the vacuum removes wound secretions and reduces edema and therefore improves blood flow, all together achieving consecutive wound closure. Since its introduction in the late 1990´s the number of indications for the V.A.C. system has steadily increased. Recently the endoluminal application of a vacuum assisted wound closure system for the closure of rectal anastomotic fistulas has been reported. Our group reported the successful closure of intrathoracic anastomotic leaks in two cases by endoscopic placement of a vacuum assisted closure system. Here we plan to study the efficacy, safety and long term outcome of E-V.A.C. to treat major intrathoracic postsurgical leaks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mediastinitis Esophageal Neoplasms Anastomotic Leakage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

E-V.A.C.

Patients that are treated with E-V.A.C.

Group Type EXPERIMENTAL

Endoscopic vacuum assisted closure

Intervention Type PROCEDURE

1. Endoscopic debridement of wound using a regular biopsy forceps.
2. Introduction via the nose and oral exteriorization of a silicone duodenal tube (Freka Tube, 15 Ch, Fresenius Kabi, Bad Homburg v.d. H. Germany)
3. Fixation of a polyurethane foam (sponge, pore size 400-600 µm, KCI, Wiesbaden Germany) to the tip of the duodenal tube with a mersilene suture (0,35mm, Johnson \& Johnson, St-Stevens-Woluwe, Belgium).
4. Trimming of the sponge to the specific wound size.
5. Endoscopic placement of the sponge in the intrathoracic leak with a grasping forceps (Olympus, Germany)
6. Application of continuous suction of 125mmHg using vacuum pump (KCI, Wiesbaden Germany).
7. Sponge exchange twice a week until wound grounds are clean and closed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic vacuum assisted closure

1. Endoscopic debridement of wound using a regular biopsy forceps.
2. Introduction via the nose and oral exteriorization of a silicone duodenal tube (Freka Tube, 15 Ch, Fresenius Kabi, Bad Homburg v.d. H. Germany)
3. Fixation of a polyurethane foam (sponge, pore size 400-600 µm, KCI, Wiesbaden Germany) to the tip of the duodenal tube with a mersilene suture (0,35mm, Johnson \& Johnson, St-Stevens-Woluwe, Belgium).
4. Trimming of the sponge to the specific wound size.
5. Endoscopic placement of the sponge in the intrathoracic leak with a grasping forceps (Olympus, Germany)
6. Application of continuous suction of 125mmHg using vacuum pump (KCI, Wiesbaden Germany).
7. Sponge exchange twice a week until wound grounds are clean and closed

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Endoluminal vacuum assisted closure E-V.A.C. Endosponnge

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients at the Medical School Hannover that present with intrathoracic postsurgical leakage that can be intubated with a regular 9.2mm diameter endoscope (Olympus GIF-165, Olympus
* Age over 18 years old
* Signed informed consent

Exclusion Criteria

* Small leakage that can be treated with clips
* Refusal to participate in study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hannover Medical School

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Gastroenterology, Hepatology and Endocrinology

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jochen Wedemeyer, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover

Hanover, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jochen Wedemeyer, MD

Role: CONTACT

+49 511 532 ext. 2406

Andrea S Schneider, MD

Role: CONTACT

+49 511 532 ext. 3307

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jochen Wedemeyer, MD

Role: primary

+49 511 532 ext. 2406

References

Explore related publications, articles, or registry entries linked to this study.

Wedemeyer J, Schneider A, Manns MP, Jackobs S. Endoscopic vacuum-assisted closure of upper intestinal anastomotic leaks. Gastrointest Endosc. 2008 Apr;67(4):708-11. doi: 10.1016/j.gie.2007.10.064.

Reference Type BACKGROUND
PMID: 18374029 (View on PubMed)

Wedemeyer J, Brangewitz M, Kubicka S, Jackobs S, Winkler M, Neipp M, Klempnauer J, Manns MP, Schneider AS. Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system. Gastrointest Endosc. 2010 Feb;71(2):382-6. doi: 10.1016/j.gie.2009.07.011. Epub 2009 Oct 30.

Reference Type DERIVED
PMID: 19879566 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Spongebop01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.